For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been less clear. Now, a new study from researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that regular mammograms may still […]
China: A new meta-analysis published in Annals of Medicine suggests that constipation may be associated with an increased risk of all-cause mortality, particularly among individuals with chronic health conditions such as chronic kidney disease (CKD) and heart failure. Interestingly, no clear link was observed between constipation and cardiovascular-specific mortality, highlighting the need for further research […]
Next to cancer recurrence or progression, cardiovascular diseases are the leading causes of death in cancer survivors. The Surveillance, Epidemiology, and End Results database revealed that among the more than three million who initially survived cancer between 1973 and 2012, 38% eventually succumbed to the disease while 11.3% died from cardiovascular diseases. Specifically, cancer survivors […]
Shimla: Pharmaceutical manufacturers in Himachal Pradesh have said the U.S. decision to impose 100% tariffs on branded and patented medicines is unlikely to cause major disruptions, as the state’s pharma sector is overwhelmingly focused on generics. The new duty, set to take effect from October 1, will apply to imported branded and patented drugs. However, […]
Mumbai: In a major crackdown on regulatory lapses, the Pharmacy Council of India (PCI) has prohibited 89 pharmacy colleges across Maharashtra, including 71 diploma and 18 degree institutions, from admitting students for the 2025-26 academic session. According to a recent media report in the Times of India, the move follows three years of inspections by […]
New Delhi: US President Donald Trump’s recent decision to impose a 100 percent import tariff on branded and patented pharmaceutical products starting October 1, 2025, is unlikely to have any immediate impact on Indian pharmaceutical exports, according to key industry players. The move, announced by Trump via his social media platform Truth Social, targets drugmakers not […]
New Delhi: Reviewing the revised Phase III clinical trial protocol for booster dose administration of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in infants, the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Novo Medi Sciences for conducting the study as per the presented protocol. This […]
A shocking allegation has been levelled against Max Hospital in Vaishali, Ghaziabad, following the death of a one-month-old baby two days ago. The family alleged that even after the baby was declared dead at 4 PM, hospital staff continued to demand money for treatment until 6 PM. According to the family, the hospital behaved insensitively […]
Through a recent notice, the Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has released an updated MBBS seat matrix, which has been prepared considering the recent changes in Renewal of existing UG (MBBS) seats as well as additional seats sanctioned for the Academic Year 2025-26. Referring to the MARB notice […]
Biotech firm Factor Bioscience has filed a lawsuit against Cellectis and AstraZeneca, accusing the companies of allegedly infringing three patents related to its gene-editing technology used in cancer treatments. The lawsuit, filed in the District federal Court, alleges that Cellectis copied Factor’s technology for designing gene-edited cells for cancer therapies. Cellectis licenses its gene-editing technology […]